Moody's Corporation has announced a public offering of €500 million in senior notes due 2033. This strategic move is expected to strengthen the company's financial position and enhance its liquidity.
The offering is particularly relevant for the consumer credit reporting industry, where Moody's competes with other firms such as Dun & Bradstreet. The notes, which carry an interest rate of 4.125%, will be Moody's senior unsecured obligations and will rank equally with its other existing and future unsubordinated indebtedness.
According to the filing, the notes will mature on November 12, 2033, with interest payments scheduled annually in arrears starting November 12, 2027. Moody's intends to apply for listing the notes on the New York Stock Exchange, indicating its commitment to maintaining a strong market presence.
In the filing, Moody's stated, "We are offering €500,000,000 aggregate principal amount of our 4.125% Senior Notes due 2033. The notes will be our senior unsecured obligations, will rank equally in right of payment with all of our other existing and future unsubordinated indebtedness and will not be convertible or exchangeable." This offering reflects the company's ongoing efforts to optimize its capital structure.
The issuance of these notes may affect various stakeholders, including investors, creditors, and competitors in the consumer credit reporting sector. The public offering price is set at 99.221% of the principal amount, with a total expected proceeds of approximately €492.98 million after deducting underwriting discounts and expenses.
The filing does not specify what happens next, but the listing application for the notes will be subject to approval by the NYSE. If approved, trading in the notes is expected to begin within 30 days after the original issue date.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










